Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study

INTRODUCTION: Migraine is a highly prevalent and disabling neurological disease. Excessive use of acute medications can lead to medication-overuse headache (MOH), occurring when a patient experiences an increasing number of headache and migraine days, despite taking greater amounts of acute medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Rigmor H., Schytz, Henrik Winther, Tassorelli, Cristina, Terwindt, Gisela M., Carlsen, Louise N., Mittoux, Aurélia, Østerberg, Ole, Lipton, Richard B., Tepper, Stewart J., Blumenfeld, Andrew, Lundqvist, Christofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994537/
https://www.ncbi.nlm.nih.gov/pubmed/36908606
http://dx.doi.org/10.3389/fneur.2023.1114654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994537/
https://www.ncbi.nlm.nih.gov/pubmed/36908606
http://dx.doi.org/10.3389/fneur.2023.1114654

Ejemplares similares